TM
STAA icon

Torren Management’s STAAR Surgical STAA Stock Holding History

Torren Management’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-181
Closed -$4.18K – 1402
2025
Q4 		$4.18K Buy
+181
New +$4.67K ﹤0.01% 942

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
Anatole Investment Management Central, Hong Kong $716M AUM 502.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Torren Management's STAA Position: Q1 2026 in Review

Torren Management sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 181 shares — an estimated $4.18K sold.

Torren Management first reported a position in STAA in Q4 2025 and held it in 1 quarter. The position peaked at $4.18K in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Torren Management reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • Torren Management sold 181 STAAR Surgical shares in Q1 2026, an estimated $4.18K.
  • Torren Management first reported a position in STAAR Surgical in Q4 2025 and held it in 1 quarter.
  • Torren Management's STAAR Surgical position peaked at $4.18K in Q4 2025.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.